BioNexus Gene Lab CEO reports zero share holdings
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
BioNexus Gene Lab Corp disclosed that CEO and director Tan Lee Su-Leng filed a Form 3 reporting her holdings of company equity securities. The report lists 0.0000 shares held directly following a holdings entry dated 2023-08-15, with no buy or sell transactions shown.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Holding | 0 | -- | -- | -- |
Key Figures
Key Terms
Rule 10b5-1 regulatory
beneficial ownership regulatory
direct_or_indirect technical
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does the BioNexus Gene Lab Corp (BGLC) Form 3 report?
Does the BioNexus Gene Lab (BGLC) Form 3 show any insider buying or selling?
What is the date associated with Tan Lee Su-Leng’s BGLC holdings entry?
Is the BGLC CEO’s reported ownership direct or indirect?
AI-generated analysis. How Rhea-AI works. Not financial advice.